- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
54.25
+0.36(+0.67%)
- Volume:62,939
- Day's Range:53.40 - 54.47
- 52 wk Range:52.08 - 155.86
TNDM Overview
- Prev. Close
- 53.89
- Day's Range
- 53.4-54.47
- Revenue
- 765.79M
- Open
- 53.86
- 52 wk Range
- 52.08-155.86
- EPS
- -0.207
- Volume
- 62,939
- Market Cap
- 3.47B
- Dividend (Yield)
- N/A(N/A)
- Average Vol. (3m)
- 981,583
- P/E Ratio
- -264.12
- Beta
- 0.781
- 1-Year Change
- -49.75%
- Shares Outstanding
- 64,221,212
- Next Earnings Date
- Nov 03, 2022
What is your sentiment on Tandem Diabetes Care?
or
Vote to see community's results!
Tandem Diabetes Care Inc Analysis
- Tandem Diabetes Care, Inc. (TNDM) Tops Q3 Earnings and Revenue Estimates
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to loss of...
- Here's Why You Should Hold on to Tandem Diabetes (TNDM) Stock
Tandem Diabetes Care (NASDAQ:TNDM), Inc. TNDM has been gaining on robust domestic and international pump sales and shipments. Its better-than-expected revenues in the fourth...
- Tandem Diabetes (TNDM) Q2 Earnings & Revenues Top Estimates
Tandem Diabetes Care (NASDAQ:TNDM), Inc. TNDM reported adjusted loss per share of 19 cents for second-quarter 2020, wider than the year-ago metric of a loss of 3 cents. However,...
Tandem Diabetes Care Inc Company Profile
Tandem Diabetes Care Inc Company Profile
Tandem Diabetes Care, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of technology solutions for people living with diabetes. The Company's manufacturing, sales, and support activities principally focus on its flagship pump platform, the t:slim X2, and its complementary product offerings. Its t:slim X2 is based on Company's technology platform and is the smallest durable insulin pump available in the United States. The Company has commercially offered two different automated insulin dosing (AID) algorithms on t:slim X2, including Control-IQ technology, which is an advanced hybrid-closed loop feature, designed to help increase a user's time in their targeted glycemic range, and Food and Drug Administration (FDA) to deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar based on continuous glucose monitoring (CGM) readings.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Buy | Buy | Strong Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Neutral | Strong Sell | Strong Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 18.34 | 18.44 | 18.15 | -0.35 | -1.90% | 1.37M | NYSE | |||
| 101.08 | 101.66 | 100.42 | +0.25 | +0.25% | 9.46M | NASDAQ | |||
| 49.67 | 50.06 | 49.57 | -0.44 | -0.88% | 1.43M | NYSE | |||
| 166.06 | 166.41 | 165.60 | +0.76 | +0.46% | 1.10M | NYSE | |||
| 200.56 | 200.83 | 199.44 | -0.32 | -0.16% | 107.00K | NASDAQ | |||
| 1.492 | 1.64 | 1.44 | +0.510 | +51.94% | 21.42M | NYSE | |||
| 3.375 | 3.375 | 3.28 | +0.025 | +0.75% | 1.34K | NASDAQ | |||
| 435.40 | 436.67 | 429.86 | +1.16 | +0.27% | 121.85K | NYSE | |||
| 13.78 | 15.06 | 13.37 | +0.83 | +6.42% | 28.59M | NASDAQ | |||
| 3.60 | 3.60 | 3.55 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 133.16 | 133.29 | 132.25 | -0.85 | -0.63% | 527.88K | NYSE | |||
| 92.51 | 93.96 | 92.38 | -2.26 | -2.38% | 2.52M | NYSE | |||
| 63.05 | 63.49 | 62.47 | -2.68 | -4.08% | 3.35M | NYSE | |||
| 0.0008 | 0.0008 | 0.0008 | 0.0000 | 0.00% | 12.50K | OTC Markets | |||
| 75.73 | 75.80 | 75.33 | +0.11 | +0.15% | 69.87K | NYSE |
- Mar 03, 2022, 03:28why does it go down after hours so much?
- Jan 25, 2021, 18:01looks like this is going back 120 and over. Earning forecast is good
- Feb 15, 2020, 01:29this one is going up, the 24th comes the earnings, and easily might reach the $100k
- Feb 15, 2020, 01:29Correction...$100
- Dec 17, 2019, 01:07TNDM has the technology equal to an artificial pancreas. Will save many diabetics lives.
- Nov 20, 2019, 06:20DID did anybody observed DarioHealth which jumped from 0.30usd to 4.11 usd ? please ?
- Oct 29, 2019, 01:13let's hit the $80 Mark his year guys!
- Nov 16, 2019, 02:25do you think is good to entry to this stock please ?
- Jan 30, 2020, 09:13yes
- Jan 30, 2020, 09:13yes
- Aug 02, 2019, 01:24Nice quarter Tandem!!!
- May 04, 2019, 15:53You guys think it can hit 80 by 2020?
- Mar 29, 2019, 17:51long added ! Come on go back up!
- Mar 27, 2019, 18:44Joy ride looks to be ending. Over-purchased and going down. Was looking forward to ~$80